JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB128879

Anti-GBA antibody [EPR5143(3)]

3

(4 Reviews)

|

(10 Publications)

Rabbit Recombinant Monoclonal GBA antibody. Suitable for IHC-P, WB and reacts with Human, Rat samples. Cited in 10 publications.

View Alternative Names

GBA, GC, GLUC, GBA1, Lysosomal acid glucosylceramidase, Lysosomal acid GCase, Acid beta-glucosidase, Alglucerase, Beta-glucocerebrosidase, Beta-glucosylceramidase 1, Cholesterol glucosyltransferase, Cholesteryl-beta-glucosidase, D-glucosyl-N-acylsphingosine glucohydrolase, Glucosylceramidase beta 1, Imiglucerase, Lysosomal cholesterol glycosyltransferase, Lysosomal galactosylceramidase, Lysosomal glycosylceramidase, Beta-GC, SGTase

9 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA antibody [EPR5143(3)] (AB128879)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA antibody [EPR5143(3)] (AB128879)

ab128879, unpurified, at a 1/100 dilution, staining GBA in paraffin embedded Human kidney tissue by Immunohistochemistry.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA antibody [EPR5143(3)] (AB128879)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA antibody [EPR5143(3)] (AB128879)

ab128879, unpurified, at a 1/100 dilution, staining GBA in paraffin embedded Human thyroid carcinoma tissue by Immunohistochemistry.

Perform heat mediated antigen retrieval before commencing with IHC staining protocol.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA antibody [EPR5143(3)] (AB128879)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-GBA antibody [EPR5143(3)] (AB128879)

ab128879 staining GBA in Human kidney tissue sections by Immunohistochemistry (IHC-P - paraformaldehyde-fixed, paraffin-embedded sections). Tissue was fixed and paraffin-embedded, antigen retrieval was by heat mediation in Tris/EDTA buffer pH9. Samples were incubated with primary antibody (1/200). An undiluted HRP-conjugated anti-rabbit IgG was used as the secondary antibody. Tissue counterstained with Hematoxylin.

Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)
  • WB

Lab

Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)

Lanes 1 - 4 : Merged signal (red and green). Green - ab128879 observed at 60 kDa. Red - loading control, ab8245, observed at 37 kDa.

ab128879 was shown to specifically react with GBA in wild-type HAP1 cells as well as additional cross reactive bands. No bands were observed when GBA knockout samples were used. Wild-type and GBA knockout samples were subjected to SDS-PAGE. ab128879 and ab8245 (Mouse anti GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/10,000 dilution respectively. Blots were developed with 800CW Goat anti-Rabbit and 680CW Goat anti-Mouse secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/1000 dilution

Lane 1:

Wild-type HAP1 whole cell lysate at 20 µg

Lane 2:

GBA knockout HAP1 whole cell lysate at 20 µg

Lane 3:

MCF7 whole cell lysate at 20 µg

Lane 4:

HepG2 whole cell lysate at 20 µg

Predicted band size: 60 kDa

false

Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)
  • WB

Lab

Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)

Lanes 1- 2 : Merged signal (red and green). Green - ab128879 observed at 60 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

ab128879 was shown to react with GBA in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab265038 (knockout cell lysate ab256929) was used. Wild-type HeLa and GBA knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab128879 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

All lanes:

Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/1000 dilution

Lane 1:

Wild-type HeLa cell lysate at 20 µg

Lane 2:

GBA knockout HeLa cell lysate at 20 µg

Lane 2:

Western blot - Human GBA knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-gba-knockout-hela-cell-line-ab265038'>ab265038</a>)

Predicted band size: 60 kDa

Observed band size: 60 kDa

false

Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)
  • WB

Supplier Data

Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)

All lanes:

Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/4000 dilution

Lane 1:

Saos-2 Cell Lysate at 20 µg

Lane 2:

U87-MG Cell Lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), HRP- conjugated at 1/1000 dilution

Predicted band size: 60 kDa

false

Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)
  • WB

Unknown

Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)

All lanes:

Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/1000 dilution

Lane 1:

293T cell lysate at 10 µg

Lane 2:

Saos-2 cell lysate at 10 µg

Lane 3:

U87-MG cell lysate at 10 µg

Secondary

All lanes:

HRP labelled goat anti-rabbit at 1/2000 dilution

Predicted band size: 60 kDa

false

Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)
  • WB

Unknown

Western blot - Anti-GBA antibody [EPR5143(3)] (AB128879)

Blocking and diluting buffers :

Lane 1 and 2 : 5% NFDM/TBST
Lane 3 and 4 : 2% BSA/TBST

We suggest using 2% BSA/TBST as blocking buffer and antibody diluting buffer if you cannot obtain strong band in some samples.

Lane 1:

Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/10000 dilution

Lanes 2 - 4:

Western blot - Anti-GBA antibody [EPR5143(3)] (ab128879) at 1/50000 dilution

All lanes:

C6 (Rat glial tumor glial cell) whole cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/100000 dilution

Predicted band size: 60 kDa

Observed band size: 60 kDa

false

Exposure time: 180s

OI-RD Scanning - Anti-GBA antibody [EPR5143(3)] (AB128879)
  • OI-RD Scanning

Unknown

OI-RD Scanning - Anti-GBA antibody [EPR5143(3)] (AB128879)

We have systematically measured KD (the equilibrium dissociation constant between the antibody and its antigen), of more than 840 recombinant antibodies to assess not only their individual KD values but also to see the average affinity of antibody. Based on the comparison with published literature values for mouse monoclonal antibodies, Recombinant antibodies appear to be on average 1-2 order of magnitude higher affinity.

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR5143(3)

Isotype

IgG

Carrier free

No

Reacts with

Rat, Human

Applications

WB, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Specificity

The lab re-tested the antibody in mouse samples without obtaining satisfactory results (tissue specific positive and negative results), therefore we are not able to guarantee the antibody in this species. Please contact our Scientific Support if you have any feedback in mouse.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/100 - 1/200", "IHCP-species-notes": "<p><strong>For unpurified use at 1/50.</strong></p> Perform heat-mediated antigen retrieval before commencing with IHC staining protocol.", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p>We suggest using 2% BSA/TBST as blocking buffer and antibody diluting buffer if you cannot obtain strong band in some samples.</p>" }, "Rat": { "IHCP-species-checked": "guaranteed", "IHCP-species-dilution-info": "", "IHCP-species-notes": "", "IP-species-checked": "notRecommended", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "notRecommended", "FlowCyt-species-dilution-info": "", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "<p>We suggest using 2% BSA/TBST as blocking buffer and antibody diluting buffer if you cannot obtain strong band in some samples.</p>" } } }

Product details

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Protein A
Storage buffer
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

GBA also known as glucosylceramidase is a lysosomal enzyme with a molecular mass of approximately 59 kDa. This enzyme breaks down glucosylceramide into glucose and ceramide. GBA is expressed predominantly in tissues with high metabolic activities such as the brain liver and spleen. Its function relies on its catalytic activity where substrates bind to its active site enabling the hydrolysis process necessary for maintaining cellular metabolism.
Biological function summary

GBA plays an important role in sphingolipid metabolism. It participates in the degradation of glycolipids within the lysosome contributing to lipid recycling. It acts independently rather than as a part of a major enzymatic complex. Through its role in degrading glucosylceramide GBA influences cellular homeostasis and bioenergetics ensuring balance in neural and systemic lipid levels.

Pathways

GBA’s enzymatic functions are integral to the glycosphingolipid metabolic pathway. It is involved in the downstream steps of the lysosomal degradation of glycosphingolipids. The pathway operates alongside other important proteins such as beta-glucosidase and CERT-related transfer proteins all of which contribute to membrane lipid organization and signal transduction processes.

GBA mutations are linked with Gaucher disease and Parkinson’s disease. In Gaucher disease deficient GBA activity leads to substrate accumulation resulting in hepatosplenomegaly and other systemic symptoms. Reduced GBA activity is also associated with increased alpha-synuclein aggregation in Parkinson’s disease implicating it in the pathogenesis of neurodegenerative disorders. The enzyme’s function in these diseases highlights its role in maintaining cellular equilibrium and signaling pathways.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Glucosylceramidase that catalyzes, within the lysosomal compartment, the hydrolysis of glucosylceramides/GlcCers (such as beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine) into free ceramides (such as N-acylsphing-4-enine) and glucose (PubMed : 15916907, PubMed : 24211208, PubMed : 32144204, PubMed : 39395789, PubMed : 9201993). Plays a central role in the degradation of complex lipids and the turnover of cellular membranes (PubMed : 27378698). Through the production of ceramides, participates in the PKC-activated salvage pathway of ceramide formation (PubMed : 19279011). Catalyzes the glucosylation of cholesterol, through a transglucosylation reaction where glucose is transferred from GlcCer to cholesterol (PubMed : 24211208, PubMed : 26724485, PubMed : 32144204). GlcCer containing mono-unsaturated fatty acids (such as beta-D-glucosyl-N-(9Z-octadecenoyl)-sphing-4-enine) are preferred as glucose donors for cholesterol glucosylation when compared with GlcCer containing same chain length of saturated fatty acids (such as beta-D-glucosyl-N-octadecanoyl-sphing-4-enine) (PubMed : 24211208). Under specific conditions, may alternatively catalyze the reverse reaction, transferring glucose from cholesteryl 3-beta-D-glucoside to ceramide (Probable) (PubMed : 26724485). Can also hydrolyze cholesteryl 3-beta-D-glucoside producing glucose and cholesterol (PubMed : 24211208, PubMed : 26724485, PubMed : 39395789). Catalyzes the hydrolysis of galactosylceramides/GalCers (such as beta-D-galactosyl-(1<->1')-N-acylsphing-4-enine), as well as the transfer of galactose between GalCers and cholesterol in vitro, but with lower activity than with GlcCers (PubMed : 32144204). Contrary to GlcCer and GalCer, xylosylceramide/XylCer (such as beta-D-xyosyl-(1<->1')-N-acylsphing-4-enine) is not a good substrate for hydrolysis, however it is a good xylose donor for transxylosylation activity to form cholesteryl 3-beta-D-xyloside (PubMed : 33361282). Can also metabolize plant glycosyl phytosterols such as glucosylstigmasterol (PubMed : 39395789).
See full target information GBA1

Publications (10)

Recent publications for all applications. Explore the full list and refine your search

Aging cell 23:e14077 PubMed38303548

2024

The SATB1-MIR22-GBA axis mediates glucocerebroside accumulation inducing a cellular senescence-like phenotype in dopaminergic neurons.

Applications

Unspecified application

Species

Unspecified reactive species

Taylor Russo,Benjamin Kolisnyk,Aswathy B S,Jonathan Plessis-Belair,Tae Wan Kim,Jacqueline Martin,Jason Ni,Jordan A Pearson,Emily J Park,Roger B Sher,Lorenz Studer,Markus Riessland

Journal of Parkinson's disease 14:65-78 PubMed38251062

2024

Characterization of Novel Human β-glucocerebrosidase Antibodies for Parkinson's Disease Research.

Applications

Unspecified application

Species

Unspecified reactive species

Tiffany Jong,Alexandra Gehrlein,Ellen Sidransky,Ravi Jagasia,Yu Chen

Nature communications 14:5804 PubMed37726325

2023

Prosaposin maintains lipid homeostasis in dopamine neurons and counteracts experimental parkinsonism in rodents.

Applications

Unspecified application

Species

Unspecified reactive species

Yachao He,Ibrahim Kaya,Reza Shariatgorji,Johan Lundkvist,Lars U Wahlberg,Anna Nilsson,Dejan Mamula,Jan Kehr,Justyna Zareba-Paslawska,Henrik Biverstål,Karima Chergui,Xiaoqun Zhang,Per E Andren,Per Svenningsson

Nature communications 14:2057 PubMed37045813

2023

Targeting neuronal lysosomal dysfunction caused by β-glucocerebrosidase deficiency with an enzyme-based brain shuttle construct.

Applications

Unspecified application

Species

Unspecified reactive species

Alexandra Gehrlein,Vinod Udayar,Nadia Anastasi,Martino L Morella,Iris Ruf,Doris Brugger,Sophia von der Mark,Ralf Thoma,Arne Rufer,Dominik Heer,Nina Pfahler,Anton Jochner,Jens Niewoehner,Luise Wolf,Matthias Fueth,Martin Ebeling,Roberto Villaseñor,Yanping Zhu,Matthew C Deen,Xiaoyang Shan,Zahra Ehsaei,Verdon Taylor,Ellen Sidransky,David J Vocadlo,Per-Ola Freskgård,Ravi Jagasia

Journal of molecular neuroscience : MN 72:2313-2325 PubMed36152140

2022

Prosaposin Reduces α-Synuclein in Cells and Saposin C Dislodges it from Glucosylceramide-enriched Lipid Membranes.

Applications

Unspecified application

Species

Unspecified reactive species

Rika Kojima,Mark Zurbruegg,Tianyi Li,Wojciech Paslawski,Xiaoqun Zhang,Per Svenningsson

International journal of molecular sciences 19: PubMed30308956

2018

Biochemical Characterization of the c.1780G>C Missense Mutation in Lymphoblastoid Cells from Patients with Spastic Ataxia.

Applications

Unspecified application

Species

Unspecified reactive species

Anna Malekkou,Maura Samarani,Anthi Drousiotou,Christina Votsi,Sandro Sonnino,Marios Pantzaris,Elena Chiricozzi,Eleni Zamba-Papanicolaou,Massimo Aureli,Nicoletta Loberto,Kyproula Christodoulou

FASEB journal : official publication of the Federa 32:5685-5702 PubMed29746165

2018

A lysosome-plasma membrane-sphingolipid axis linking lysosomal storage to cell growth arrest.

Applications

Unspecified application

Species

Unspecified reactive species

Maura Samarani,Nicoletta Loberto,Giulia Soldà,Letizia Straniero,Rosanna Asselta,Stefano Duga,Giulia Lunghi,Fabio A Zucca,Laura Mauri,Maria Grazia Ciampa,Domitilla Schiumarini,Rosaria Bassi,Paola Giussani,Elena Chiricozzi,Alessandro Prinetti,Massimo Aureli,Sandro Sonnino

Scientific reports 7:12702 PubMed28983119

2017

The GBAP1 pseudogene acts as a ceRNA for the glucocerebrosidase gene GBA by sponging miR-22-3p.

Applications

Unspecified application

Species

Unspecified reactive species

Letizia Straniero,Valeria Rimoldi,Maura Samarani,Stefano Goldwurm,Alessio Di Fonzo,Rejko Krüger,Michela Deleidi,Massimo Aureli,Giulia Soldà,Stefano Duga,Rosanna Asselta

Neurobiology of aging 36:2649-59 PubMed26149921

2015

Increased oligomerization and phosphorylation of α-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains.

Applications

WB

Species

Cynomolgus monkey

Guangwei Liu,Min Chen,Na Mi,Weiwei Yang,Xin Li,Peng Wang,Na Yin,Yaohua Li,Feng Yue,Piu Chan,Shun Yu

Clinical cardiology 11:311-6 PubMed2898311

1988

Clinical assessment of beta blockade.

Applications

WB

Species

Unspecified reactive species

M W Weston,S P Glasser,D J Stoner,G H Lyman
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com